课题基金 / 基金详情

PHYSICIAN SCIENTIST TRAINING GRANT IN ONCOLOGY

PHYSICIAN SCIENTIST TRAINING GRANT IN ONCOLOGY
肿瘤学医师科学家培训补助金
批准号:
6375471
负责人:
CHRIS H. TAKIMOTO
金额:
$42.47万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-05 至 2003-06-30

项目摘要

项目成果

CHRIS H. TAKIMOTO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Many institutions can train outstanding clinical oncologists, however, few institutions contain the necessary elements required to train these young clinicians for a career in investigation. San Antonio has a long history of boil basic and clinical cancer research and has developed major expertise in cooperative group trials, investigational drug development, breast cancer research, and bone marrow transplant. To obtain excellence in these areas, basic and clinical investigators have worked closely together. Recently, through the joint efforts of the University of Texas Health Science Center (UTHSCSA) and the Cancer Therapy and Research Center (CTRC), the cancer research efforts have been organized into San Antonio Cancer Institute (SACI), an NCI designated comprehensive cancer center. As described in this application, San Antonio can provide trainees with appropriate research experience, didactic instruction, and mentoring to begin a career in clinical cancer research. Our program will identify physician candidate trainees from medical, surgical, and radiation oncology. An Advisory Committee composed of key members of SACI and the clinical chairs of UTHSCSA will provide oversight for the training program. Trainees will be supported for two years on this training grant. Each trainee will select a SACI member as a mentor for their training in laboratory research skills. Once selected, Research Committee will be formed to provide detailed oversight of the trainee's progress. At the end of the first year of research support, the trainee will submit a clinical investigation proposal. The proposal will be designed to generate sufficient data to launch their research career. At the end of two years of support, th trainee will return to their clinical department as junior faculty members to continue their career development. Thus, this training program will allow young clinicians to develop an area of research expertise and bring this expertise back to their "home" clinical department.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
基于新的生物素化培养地扩展测定法,用于研究端粒酶抑制剂的人类乳腺癌模型。
DOI: 10.1038/sj.bjc.6690526
发表时间: 1999-07
期刊: BRITISH JOURNAL OF CANCER
影响因子: 8.8
作者: [Raymond, E, Sun, D, Izbicka, E, Mangold, G, Silvas, E, Windle, B, Sharma, S, Soda, H, Laurence, R, Davidson, K, Von Hoff, DD]
通讯作者: Von Hoff, DD
Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line.
二甲亚砜 (DMSO) 可逆性抑制伯基特淋巴瘤细胞系中的端粒酶活性。
DOI: 10.1016/s0145-2126(97)00188-4
发表时间: 1998
期刊: Leukemia research
影响因子: 2.7
作者: [Sharma,S, Raymond,E, Soda,H, Izbicka,E, Davidson,K, Lawrence,R, VonHoff,DD]
通讯作者: VonHoff,DD
DOI: 10.1182/blood.v87.4.1495.bloodjournal8741495
发表时间: 1996-02-15
期刊: BLOOD
影响因子: 20.3
作者: [Alsina, M, Boyce, B, Roodman, GD]
通讯作者: Roodman, GD
An in vivo model of human multiple myeloma bone disease.
人类多发性骨髓瘤骨病的体内模型。
DOI: --
发表时间: 1995
期刊: Stem cells (Dayton, Ohio)
影响因子: --
作者: [Alsina,M, Boyce,BF, Mundy,GR, Roodman,GD]
通讯作者: Roodman,GD
8
    PH I STUDY OF BMS-247550 GIVEN ON CONTINUOUS WEEKLY SCHEDULE IN PTS W/ADV MALIG
    PH I PK STUDY OF PS341 IN PTS WITH ADVANCED MALIGNANCIES AND RENAL DYSFUNCTION
    PH I STUDY OF BMS-247550 GIVEN ON CONTINUOUS WEEKLY SCHEDULE IN PTS W/ADV MALIG
    Ph I Pharmacokinetics of STI571 in Cancer & Liver Dis
    海外基金